In a licensing deal unveiled Monday, Lyell Immunopharma is handing over $40 million in cash and almost 2 million of its ...

Total neoadjuvant treatment (TNT) may offer a promising alternative to surgery for patients with stage I rectal cancer (S1RC), a small study finds. 1 Among patients treated, TNT achieved a 93.7% ...

Many cancer types — breast, prostate, skin cancer — have 5-year survival rates and ample treatment options if caught early.

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...

Study researchers found no link between more liver fat and poor outcomes in patients with stage I-III rectal cancer.

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...

Bowel-related symptoms persist for up to 5 years after colorectal cancer, and higher dietary fiber intake is associated with ...